Biologica debuts with a $7 million seed round, launching daily health products tailored for women

The seed round was led by Addition, with backing from Hawktail (Michael Polansky), Greycroft (Katherine Power), True Beauty Ventures (Cristina Nuñez), Good Friends (the founders of Warby Parker, Harry's and Flamingo), as well as Gabrielle Bernstein and Katherine Schwarzenegger Pratt.

Biologica aims to provide targeted, great-tasting support specific to each hormonal shift, packaged into a single, easy-to-follow daily routine. | Image source: biologica.com
WT default author logo
Women's Tabloid News Desk

Biologica has officially launched with a new line of daily health products tailored to women across three key hormonal phases: the reproductive years, perimenopause, and postmenopause. The brand, founded by Liz Zwillinger alongside Allbirds co-founder Joey Zwillinger, is built on the belief that hormones are central to women’s overall wellbeing, a factor they argue has long been overlooked in the supplements space. Biologica aims to provide targeted, great-tasting support specific to each hormonal shift, packaged into a single, easy-to-follow daily routine.

The company’s launch is accompanied by a $7 million seed round led by Addition, with backing from Hawktail (Michael Polansky), Greycroft (Katherine Power), True Beauty Ventures (Cristina Nuñez), Good Friends (the founders of Warby Parker, Harry’s and Flamingo), as well as Gabrielle Bernstein and Katherine Schwarzenegger Pratt.

“For me, the hardest part was never having a simple solution to help alleviate my hormonal symptoms that were worsening with age. When I started talking openly with other women, I realized my experience wasn’t unique at all. We were all navigating the same shifts without clear support and many women were overwhelmed with all the options. Biologica became a way to finally give women targeted tools that meet us where we are, at every stage,” said Elizabeth Zwilliger, co-founder of Biologica.

To ensure each product was grounded in research, Biologica brought together a medical advisory board made up of practising OB/GYNs, a breast-cancer surgeon, and naturopathic doctors specialising in women’s health. Their input shaped the formulations, which use clinically-studied ingredients at research-backed levels to address the most pressing symptoms associated with every hormonal phase. Some issues affect women more frequently than men throughout life, prompting the inclusion of a targeted probiotic strain and carefully calibrated levels of Vitamin B-complex and electrolytes across all three products in the range.

“Biologica required me to listen in a completely new way because I’ll never personally experience the impact from hormonal fluctuations. As we developed our product, my lack of lived experience led me to lean on the wisdom of women from the focus groups we conducted and our 1,000-woman health study, to our expert medical advisory board, and of course, from Liz directly. This wasn’t about adding another supplement to the shelf. We set out to unlearn assumptions and rethink the approach in order to address women’s real needs at each life stage,” adds Joey Zwillinger, co-founder.

With its initial range now on the market, Biologica positions itself as a new entrant in women’s health that seeks to bring scientifically informed, stage-specific support into a daily routine built around convenience.

Share:

Related Insights

Jeito Capital secures record $1.2 billion to drive biopharma innovation

Minor Hotels reveals global AI platform to transform guest services

Noom acquires licensed pharmacy to expand into healthy aging and preventive care

Blackstone and TPG complete acquisition of Hologic with new chief executive at the helm

Adela Ida Jiram appointed as first Iban woman to lead MSPTM

New menopause action plan comes at right time as survey shows just 18% of women’s work have menopause policy

Prickly Pear Health expands pre-seed funding for women’s brain health

KWAP joins Lestari Cooling Energy as new investor to drive district cooling